GTR Test Accession:
Help
GTR000607985.1
Registered in GTR:
2023-08-16
View version history
GTR000607985.1,
registered in GTR:
2023-08-16
Last annual review date for the lab: 2024-08-23
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Prognostic;
Risk Assessment; ...
Conditions (11):
Help
Genes (16):
Help
Methods (1):
Help
Molecular Genetics - Targeted variant analysis: SNP Detection
Target population: Help
Risk for pancreatic disease and comorbidities including hyperlipidemia, gallstone, celiac …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Avoidance of invasive testing;
Establish or confirm diagnosis;
Guidance for management; ...
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Buccal swab
- Peripheral (whole) blood
- Saliva
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Physician
- Nurse Practitioner
- Physician Assistant
Lab contact:
Help
David Finegold, MD, ABMGG Board Certified, ABP, Diplomate of the American Board of M, Lab Director
info@arielmedicine.com
(844) 692-7435
info@arielmedicine.com
(844) 692-7435
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
1) Clinician logs in to Ariel's website and orders test for an appropriate patient.
Order URL
Order URL
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
Result interpretation
Result interpretation
Test development:
Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required:
Help
Yes
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test Order Code,
Test strategy
Conditions
Help
Total conditions: 11
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 16
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Targeted variant analysis
SNP Detection
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis;
Prognostic;
Risk Assessment;
Screening
Clinical utility:
Help
Avoidance of invasive testing
Establish or confirm diagnosis
Guidance for management
Lifestyle planning
View citations (1)
- Rebholz C, Krawczyk M, Lammert F. Genetics of gallstone disease. Eur J Clin Invest. 2018;48(7):e12935. doi:10.1111/eci.12935. Epub 2018 May 09. PMID: 29635711.
Establish or confirm diagnosis
View citations (1)
- Genetics of pancreatitis. LaRusch J, et al. Curr Opin Gastroenterol. 2011;27(5):467-74. doi:10.1097/MOG.0b013e328349e2f8. PMID: 21844754.
Guidance for management
View citations (1)
- Rebholz C, Krawczyk M, Lammert F. Genetics of gallstone disease. Eur J Clin Invest. 2018;48(7):e12935. doi:10.1111/eci.12935. Epub 2018 May 09. PMID: 29635711.
Lifestyle planning
View citations (1)
- Whitcomb DC, LaRusch J, Krasinskas AM, Klei L, Smith JP, Brand RE, Neoptolemos JP, Lerch MM, Tector M, Sandhu BS, Guda NM, Orlichenko L, , Alkaade S, Amann ST, Anderson MA, Baillie J, Banks PA, Conwell D, Coté GA, Cotton PB, DiSario J, Farrer LA, Forsmark CE, Johnstone M, Gardner TB, Gelrud A, Greenhalf W, Haines JL, Hartman DJ, Hawes RA, Lawrence C, Lewis M, Mayerle J, Mayeux R, Melhem NM, Money ME, Muniraj T, Papachristou GI, Pericak-Vance MA, Romagnuolo J, Schellenberg GD, Sherman S, Simon P, Singh VP, Slivka A, Stolz D, Sutton R, Weiss FU, Wilcox CM, Zarnescu NO, Wisniewski SR, O'Connell MR, Kienholz ML, Roeder K, Barmada MM, Yadav D, Devlin B. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet. 2012;44(12):1349-54. doi:10.1038/ng.2466. Epub 2012 Nov 11. PMID: 23143602.
Target population:
Help
Risk for pancreatic disease and comorbidities including hyperlipidemia, gallstone, celiac disease, pancreatic cancer polygenic risk score, diabetes polygenic risk score, pancreatic acinar cell dysfunction, pancreatic ductal cell dysfunction.
Recommended fields not provided:
Clinical validity,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Confirmation:
Help
Sequencing Confirmation
Availability:
Help
Tests performed
Interpretation performed in-house
Report generated in-house
Specimen preparation performed in-house
Wet lab work performed at an outside lab
Test performance comments
Ariel Precision Medicine 5750 Centre Ave Suite 270 Pittsburgh PA 15206 Eremid Genomic Services, LLC 150 N. Research campus Drive Kannapolis, NC 28081
Interpretation performed in-house
Report generated in-house
Specimen preparation performed in-house
Wet lab work performed at an outside lab
Test performance comments
Ariel Precision Medicine 5750 Centre Ave Suite 270 Pittsburgh PA 15206 Eremid Genomic Services, LLC 150 N. Research campus Drive Kannapolis, NC 28081
Analytical Validity:
Help
Core metrics include sensitivity, specificity, and concordance. Pre-specified validation metrics require these to be calculated for each variant type, including single nucleotide variations (SNV), insertion/deletion variants (INDEL), and copy-number variants (CNV). All of these metrics were expected to perform at a minimum of 95% or greater. High-confidence SNV and INDEL …
View more
Assay limitations:
Help
SNP data may be limited compared to sequencing and comprehensive gene testing because it does not provide discovery
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
No
Description of internal test validation method: Help
Core metrics include sensitivity, specificity, and concordance. Pre-specified validation metrics require these to be calculated for each variant type, including single nucleotide variations (SNV), insertion/deletion variants (INDEL), and copy-number variants (CNV). All of these metrics were expected to perform at a minimum of 95% or greater. High-confidence SNV and INDEL … View more
No
Description of internal test validation method: Help
Core metrics include sensitivity, specificity, and concordance. Pre-specified validation metrics require these to be calculated for each variant type, including single nucleotide variations (SNV), insertion/deletion variants (INDEL), and copy-number variants (CNV). All of these metrics were expected to perform at a minimum of 95% or greater. High-confidence SNV and INDEL … View more
Recommended fields not provided:
Citations to support assay limitations,
Citations to support internal test validation method,
Citations for Analytical validity,
PT Provider,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Reviews:
Clinical resources:
Practice guidelines:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.